ACADIA Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US0042251084

SecurityACAD / ACADIA Pharmaceuticals Inc.
InstitutionGhost Tree Capital, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Ghost Tree Capital, LLC ownership in ACAD / ACADIA Pharmaceuticals Inc.

On November 14, 2024 - Ghost Tree Capital, LLC filed a 13F-HR form disclosing ownership of 0 shares of ACADIA Pharmaceuticals Inc. (US:ACAD) valued at $0 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 225,000 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Ghost Tree Capital, LLC has a history of taking positions in derivatives of the underlying security (ACAD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ACAD / ACADIA Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -225,000 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 225,000 0 0.00 3,656 -12.12 1.1449
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 225,000 175,000 350.00 4,160 165.81 1.1515
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 50,000 -30,000 -37.50 1,566 -6.12 0.5118
2023-11-14 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 80,000 80,000 1,667 0.5483
2020-11-16 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -165,000 -100.00 0 -100.00
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 165,000 165,000 7,998 2.1102
2020-04-09 2019-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 0 -750,000 -100.00 0 -100.00
2020-04-09 2019-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 750,000 -150,000 -16.67 20,048 -17.04 4.1582
2019-08-14 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 750,000 -150,000 20,048 4,198,657.1334
2020-04-09 2019-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 900,000 775,000 620.00 24,165 1,095.70 6.3134
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 900,000 775,000 24,165 6,546,953.0185
2020-04-09 2018-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 125,000 -375,000 -75.00 2,021 -80.53 0.7335
2019-02-14 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 125,000 -375,000 2,021 708,908.8907
2020-04-09 2018-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 500,000 -35,000 -6.54 10,380 27.07 2.2063
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 500,000 -35,000 10,380 2,211,126.3537
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 535,000 135,000 33.75 8,169 -9.11 2.4041
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 400,000 400,000 8,988 1.8184
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -275,000 -100.00 0 -100.00
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 275,000 -75,000 -21.43 7,670 -36.26 1.5943
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 350,000 250,000 250.00 12,033 317.23 2.2427
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 100,000 -100,000 -50.00 2,884 -54.67 0.6941
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 200,000 200,000 0.00 6,362 1.0318
2016-08-12 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -75,000 -100.00 0 -100.00
2016-05-16 2016-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 75,000 -175,000 -70.00 2,097 -76.47 1.1866
2016-05-13 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 75,000 2,097
2016-02-17 2015-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 250,000 250,000 0.00 8,913 3.6494
2015-08-14 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -120,000 -100.00 0 -100.00
2015-05-15 2015-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 120,000 120,000 3,911 1.4064
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM Call 200,000 3,698 n/a n/a n/a
2020-04-09 2018-12-31 13F/A ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-09 2018-09-30 13F/A ACADIA PHARMACEUTICALS COM Call 500,000 10,380 n/a n/a n/a
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM Call 500,000 7,000 n/a n/a n/a
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM Call 109,000 4,106 n/a n/a n/a
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM Call 350,000 10,094 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM Put 207,200 7,124 n/a n/a n/a
2016-08-12 2016-06-30 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-16 2016-03-31 13F/A ACADIA PHARMACEUTICALS COM Put 350,000 9,786 n/a n/a n/a
2016-05-13 2016-03-31 13F ACADIA PHARMACEUTICALS COM Put 350,000 9,786 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.